The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients

G. Michael Felker, Weimin Hu, Joshua Hare, Ralph H. Hruban, Kenneth L. Baughman, Edward K. Kasper

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

This report describes the evaluation of 1,278 patients referred to The Johns Hopkins Hospital with dilated cardiomyopathy. After a careful history and physical examination, selected laboratory tests, and endomyocardial biopsy, a specific diagnosis was made in 49% of cases. In 16% of cases the biopsy demonstrated a specific histologic diagnosis. Myocarditis and coronary artery disease were the most frequent specific diagnoses; 51% of patients were classified as idiopathic. Thus a rigorous and systematic search can demonstrate an underlying cause for approximately one-half of patients with unexplained cardiomyopathy. Endomyocardial biopsy plays a crucial role in this evaluation. Six cases are presented which demonstrate the utility of endomyocardial biopsy in specific clinical situations. In addition to its routine use in monitoring rejection in heart transplant recipients, endomyocardial biopsy is indicated in the evaluation of possible infiltrative cardiomyopathy, in differentiating restrictive cardiomyopathy from constrictive pericarditis, and in diagnosing and monitoring doxorubicin cardiotoxicity. The importance of diagnosing myocarditis remains controversial, and disagreement persists about the utility of immunosuppressive therapy in these patients. A combination of clinical and histologic features can divide patients with myocarditis into 4 subgroups- acute, fulminant, chronic active, and chronic persistent. This classification provides prognostic information and may identify those patients who may respond to immunosuppression, as well as those likely to have adverse outcomes from such treatment. The continued development of novel molecular techniques may allow endomyocardial biopsy to provide greater prognostic and therapeutic information in the future.

Original languageEnglish
Pages (from-to)270-283
Number of pages14
JournalMedicine
Volume78
Issue number4
DOIs
StatePublished - Jul 1 1999
Externally publishedYes

Fingerprint

Dilated Cardiomyopathy
Biopsy
Myocarditis
Cardiomyopathies
Restrictive Cardiomyopathy
Constrictive Pericarditis
Immunosuppressive Agents
Doxorubicin
Immunosuppression
Physical Examination
Coronary Artery Disease
History
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. / Felker, G. Michael; Hu, Weimin; Hare, Joshua; Hruban, Ralph H.; Baughman, Kenneth L.; Kasper, Edward K.

In: Medicine, Vol. 78, No. 4, 01.07.1999, p. 270-283.

Research output: Contribution to journalArticle

Felker, G. Michael ; Hu, Weimin ; Hare, Joshua ; Hruban, Ralph H. ; Baughman, Kenneth L. ; Kasper, Edward K. / The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. In: Medicine. 1999 ; Vol. 78, No. 4. pp. 270-283.
@article{c46c03cdca624d92a25f5009ba35a8d2,
title = "The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients",
abstract = "This report describes the evaluation of 1,278 patients referred to The Johns Hopkins Hospital with dilated cardiomyopathy. After a careful history and physical examination, selected laboratory tests, and endomyocardial biopsy, a specific diagnosis was made in 49{\%} of cases. In 16{\%} of cases the biopsy demonstrated a specific histologic diagnosis. Myocarditis and coronary artery disease were the most frequent specific diagnoses; 51{\%} of patients were classified as idiopathic. Thus a rigorous and systematic search can demonstrate an underlying cause for approximately one-half of patients with unexplained cardiomyopathy. Endomyocardial biopsy plays a crucial role in this evaluation. Six cases are presented which demonstrate the utility of endomyocardial biopsy in specific clinical situations. In addition to its routine use in monitoring rejection in heart transplant recipients, endomyocardial biopsy is indicated in the evaluation of possible infiltrative cardiomyopathy, in differentiating restrictive cardiomyopathy from constrictive pericarditis, and in diagnosing and monitoring doxorubicin cardiotoxicity. The importance of diagnosing myocarditis remains controversial, and disagreement persists about the utility of immunosuppressive therapy in these patients. A combination of clinical and histologic features can divide patients with myocarditis into 4 subgroups- acute, fulminant, chronic active, and chronic persistent. This classification provides prognostic information and may identify those patients who may respond to immunosuppression, as well as those likely to have adverse outcomes from such treatment. The continued development of novel molecular techniques may allow endomyocardial biopsy to provide greater prognostic and therapeutic information in the future.",
author = "Felker, {G. Michael} and Weimin Hu and Joshua Hare and Hruban, {Ralph H.} and Baughman, {Kenneth L.} and Kasper, {Edward K.}",
year = "1999",
month = "7",
day = "1",
doi = "10.1097/00005792-199907000-00005",
language = "English",
volume = "78",
pages = "270--283",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients

AU - Felker, G. Michael

AU - Hu, Weimin

AU - Hare, Joshua

AU - Hruban, Ralph H.

AU - Baughman, Kenneth L.

AU - Kasper, Edward K.

PY - 1999/7/1

Y1 - 1999/7/1

N2 - This report describes the evaluation of 1,278 patients referred to The Johns Hopkins Hospital with dilated cardiomyopathy. After a careful history and physical examination, selected laboratory tests, and endomyocardial biopsy, a specific diagnosis was made in 49% of cases. In 16% of cases the biopsy demonstrated a specific histologic diagnosis. Myocarditis and coronary artery disease were the most frequent specific diagnoses; 51% of patients were classified as idiopathic. Thus a rigorous and systematic search can demonstrate an underlying cause for approximately one-half of patients with unexplained cardiomyopathy. Endomyocardial biopsy plays a crucial role in this evaluation. Six cases are presented which demonstrate the utility of endomyocardial biopsy in specific clinical situations. In addition to its routine use in monitoring rejection in heart transplant recipients, endomyocardial biopsy is indicated in the evaluation of possible infiltrative cardiomyopathy, in differentiating restrictive cardiomyopathy from constrictive pericarditis, and in diagnosing and monitoring doxorubicin cardiotoxicity. The importance of diagnosing myocarditis remains controversial, and disagreement persists about the utility of immunosuppressive therapy in these patients. A combination of clinical and histologic features can divide patients with myocarditis into 4 subgroups- acute, fulminant, chronic active, and chronic persistent. This classification provides prognostic information and may identify those patients who may respond to immunosuppression, as well as those likely to have adverse outcomes from such treatment. The continued development of novel molecular techniques may allow endomyocardial biopsy to provide greater prognostic and therapeutic information in the future.

AB - This report describes the evaluation of 1,278 patients referred to The Johns Hopkins Hospital with dilated cardiomyopathy. After a careful history and physical examination, selected laboratory tests, and endomyocardial biopsy, a specific diagnosis was made in 49% of cases. In 16% of cases the biopsy demonstrated a specific histologic diagnosis. Myocarditis and coronary artery disease were the most frequent specific diagnoses; 51% of patients were classified as idiopathic. Thus a rigorous and systematic search can demonstrate an underlying cause for approximately one-half of patients with unexplained cardiomyopathy. Endomyocardial biopsy plays a crucial role in this evaluation. Six cases are presented which demonstrate the utility of endomyocardial biopsy in specific clinical situations. In addition to its routine use in monitoring rejection in heart transplant recipients, endomyocardial biopsy is indicated in the evaluation of possible infiltrative cardiomyopathy, in differentiating restrictive cardiomyopathy from constrictive pericarditis, and in diagnosing and monitoring doxorubicin cardiotoxicity. The importance of diagnosing myocarditis remains controversial, and disagreement persists about the utility of immunosuppressive therapy in these patients. A combination of clinical and histologic features can divide patients with myocarditis into 4 subgroups- acute, fulminant, chronic active, and chronic persistent. This classification provides prognostic information and may identify those patients who may respond to immunosuppression, as well as those likely to have adverse outcomes from such treatment. The continued development of novel molecular techniques may allow endomyocardial biopsy to provide greater prognostic and therapeutic information in the future.

UR - http://www.scopus.com/inward/record.url?scp=0032854585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032854585&partnerID=8YFLogxK

U2 - 10.1097/00005792-199907000-00005

DO - 10.1097/00005792-199907000-00005

M3 - Article

C2 - 10424207

AN - SCOPUS:0032854585

VL - 78

SP - 270

EP - 283

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 4

ER -